| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 06/05/2002 | EP1209987A1 Composition for preventing iodine deficiency |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1121117B1 Oxaliplatinum preparation packaging |
| 06/05/2002 | EP1117299A4 Stable glycerin iodine concentrate compositions |
| 06/05/2002 | EP1023035B1 Stomatic composition |
| 06/05/2002 | EP1009376B1 Cosmetic or dermo-phamaceutical products compatible with cutaneous ecology |
| 06/05/2002 | EP0809506B1 Antimicrobial composition composed of controlled release glasses |
| 06/05/2002 | EP0786993B1 Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and their use in the treatment of metabolic and cardiovascular disorders |
| 06/05/2002 | CN1352562A Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352551A Preparations for the application of anti-inflammatory agents |
| 06/05/2002 | CN1351880A Pus drawing out paste for expelling wind and removing obstruction in channels and its preparing method |
| 06/05/2002 | CN1085947C Powder prepared with colophony, realgar and Huangdan |
| 06/04/2002 | US6399664 Administration of reactive oxygen intermediates, and more specifically ozone, for modulating the immune and hematopoietic systems of mammals having cancer; especially treating chronic myeloid leukemia |
| 06/04/2002 | US6399114 Nutritional system for nervous system disorders |
| 06/04/2002 | US6399108 Compositions and methods for the treatment of skin disorders |
| 06/04/2002 | US6399107 Use of inhibitors of gag synthesis for the treatment of corneal haze |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 05/30/2002 | WO2002041905A1 Composition comprising sodium, potassium, calcium and magnesium |
| 05/30/2002 | WO2002041904A1 Method for treating hiv |
| 05/30/2002 | WO2002041903A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/30/2002 | WO2002041885A2 Treatment of inflammation and associated complications using pseudohalides |
| 05/30/2002 | WO2002020653A3 Antimicrobial adhesive latexes, methods of making thereof, and carpet articles containing same |
| 05/30/2002 | WO2000060953A3 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/30/2002 | US20020065311 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/30/2002 | US20020065214 Method of treating congestive heart failure |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020062835 Methods of modulating hair growth |
| 05/30/2002 | CA2430202A1 Method for treating hiv |
| 05/29/2002 | EP1208338A1 Methods and apparatus for producing phase change ice particulate saline slurries |
| 05/29/2002 | EP1207875A1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 05/29/2002 | EP1207861A1 Treatment of fungal infections utilizing a fungal growth medium |
| 05/29/2002 | EP1207859A1 Oral form of administration containing probiotic micro-organisms |
| 05/29/2002 | EP1207852A1 Controlled release oral dosage suitable for oral administration |
| 05/29/2002 | EP1207848A1 Purifying and/or regenerating agent |
| 05/29/2002 | EP1207840A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 05/29/2002 | EP1207807A2 Method for inducing hypothermia |
| 05/29/2002 | EP0923382B1 Compositions of plant carbohydrates as dietary supplements |
| 05/29/2002 | DE10059053A1 Anticoagulant composition containing anticoagulant in acidic solution or suspension useful e.g. for treatment of thrombosis and for promotion of wound healing |
| 05/29/2002 | CN1350863A Medicine for treating onychomycosis |
| 05/29/2002 | CN1350857A Face-beautifying ointment and its preparing process |
| 05/29/2002 | CN1350854A Full-natural medicine for treating calculus |
| 05/29/2002 | CN1085541C Chinese medicine for treating calculus hydrops of liver, gall and kidney (CN) |
| 05/29/2002 | CN1085539C Enema for rescuring patient suffering from renal syndrome-hemorrhagic feverenal failure |
| 05/29/2002 | CN1085538C Chinese medicine for curing gastric cancer and esophagus cancer |
| 05/29/2002 | CN1085537C Hog cholera treating medicine |
| 05/29/2002 | CN1085530C External use medicine for treating open wound |
| 05/28/2002 | US6395307 Forming a protective coating on gastrointestinal mucosal tissue for treating reflux oesophagitis, gastritis, dyspepsia or peptic ulceration |
| 05/28/2002 | US6395293 Biodegradable implant precursor |
| 05/28/2002 | US6395289 Hydrophilic polymer blends used to prevent cow skin infections |
| 05/23/2002 | WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | WO2002040052A1 Inhalation of nitric oxide |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002039978A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/23/2002 | WO2002039963A1 Antifungal nail composition and method of use |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2001085115A3 High cleaning dentifrice |
| 05/23/2002 | US20020061870 Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
| 05/23/2002 | US20020061837 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 05/23/2002 | US20020061338 Solid preparation for dialysis and process for producing the same |
| 05/23/2002 | US20020061300 Method and composition for treating prostate cancer |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | CA2431651A1 Antifungal nail composition and method of use |
| 05/23/2002 | CA2429224A1 Inhalation of nitric oxide |
| 05/23/2002 | CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/22/2002 | EP1206518A1 Color safe laundry methods employing zwitterionic formulation components |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206269A1 Compositions and methods for the treatment of skin disorders |
| 05/22/2002 | EP1206266A2 Formulations for parenteral use of estramustine phosphate and albumin |
| 05/22/2002 | EP1206256A2 Combination therapy using pentafluorobenzenesulfonamide and platin compound |
| 05/22/2002 | EP1206251A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| 05/22/2002 | EP0519023B1 Folded sheet means |
| 05/22/2002 | CN1350466A A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes |
| 05/22/2002 | CN1349812A Composite medicine for treating myocardosis and its prepn |
| 05/22/2002 | CN1085096C Ointment for curing burn, empyrosis and wound infection and preparation method thereof |
| 05/22/2002 | CN1085095C Preparation method of medicine Huanshen xingnao for curing encephalomyelopathy |
| 05/22/2002 | CN1085086C Capsule for treatment of AIDS and preparing mehtod thereof |
| 05/22/2002 | CN1085077C Far infrared plaster |
| 05/21/2002 | US6392068 Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391289 Use of sunscreen combinations comprising, as essential constituent, 4,4′-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 05/21/2002 | CA1341359C Manufacturing process for a single-cell lifeform killing or growth inhibiting composition containing fluorine (f-) and lithium (li+) |
| 05/17/2002 | CA2325041A1 Ultra-vit. plus |
| 05/16/2002 | WO2002038500A2 Process for the rehydration of magaldrate powder |
| 05/16/2002 | WO2002038266A1 Apparatus and method for producing antimicrobial silver solution |
| 05/16/2002 | WO2002038077A2 L-histidine in ophthalmic solutions |
| 05/16/2002 | WO2002020026A3 Treatment of drug resistant organisms with nitric oxide |
| 05/16/2002 | WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2002 | US20020058238 Stop smoking method and composition |
| 05/16/2002 | US20020058072 Use of iodide salt as an aphrodisiac |
| 05/16/2002 | US20020058052 Amphipatic lipid containing a hydroxy and amide group; and of a surfactant in an aqueous medium; a washing-away type cosmetic composition comprising the dispersion |
| 05/15/2002 | EP1205183A2 Antimicrobial composition containing cellulose acetate |
| 05/15/2002 | EP1204870A2 Method for determining physiological effects of hemoglobin |
| 05/15/2002 | EP1204434A1 Tissue augmentation material and methods |
| 05/15/2002 | EP1204417A2 Parenteral cisplatin emulsion |
| 05/15/2002 | EP1204407A2 Implantable active ingredient depot |
| 05/15/2002 | EP1102594B1 Use of sodium chloride to reduce the gastrointestinal toxicity of camptothecin derivatives |
| 05/15/2002 | CN1349406A Combined preparations comprising morpholine anthracyclines and anticancer agent |